B · Normal
On September 24th, U.S. pharmaceutical stocks bucked the market trend and rose. Eli Lilly rose nearly 4%, Pfizer rose more than 2%, Merck, Johnson & Johnson rose nearly 2%, Novartis Pharmaceuticals and Novo Nordisk rose more than 1%; AI medical concept stock Tempus AI rose nearly 5%.
Comments